Ginsenoside Rb1 inhibits autophagy through regulation of Rho/ROCK and PI3K/mTOR pathways in a pressure-overload heart failure rat model

Tianrui, Yang, Yunbo, Miao, Tong, Zhang, Ninghui, Mu, Libo, Ruan, Jinlan, Duan, Ying, Zhu, Rongping, Zhang

Journal of Pharmacy and Pharmacology |

Objective This study was designed to explore the relationship between gin- senoside Rb1 (Grb1) and high-load heart failure (HF) in rats. Methods The parameters of cardiac systolic function (left ventricular posterior wall thickness (LVPWT), left ventricular internal diastolic diameter (LVID), frac- tion shortening (FS) and mitral valves (MVs)) of rat hearts in each group were inspected by echocardiogram. The expressions of rat myocardial contractile pro- teins, autophagy-related proteins and the activation of Rho/ROCK and PI3K/ mTOR pathways were detected by Western blot. Key findings LVPWT, FS, MVs and the expression of myocardial contractile proteins a-MHC, apoptosis-related proteins Bcl-2 and signalling pathway involved proteins pAkt and mTOR were significantly reduced in the HF, HF+5 mg/kg Grb1 (HF+Grb1-5) and HF+Grb1+arachidonic acid (AA) groups with LVID, b-MHC, cell apoptosis, cell autophagy and Rho/ROCK significantly increased compared with the control group, of which the tendency was contrary to the HF+20 mg/kg Grb1 (HF+Grb1-20) group compared with the HF group (P < 0.05). In the HF+Grb1+AA group, there was no significant change in the above indexes compared with the HF group. Conclusions The results indicated that Grb1 can exert anti-HF function by inhibiting cardiomyocyte autophagy of rats through regulation of Rho/ROCK and PI3K/mTOR pathways.